Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Antares Pharma, Inc.
Ewing, New Jersey, United States of Americaantarespharma.com ↗
- Ownership
- Private
- Employees
- ~201
- Development stage
- Other
01
Overview
Antares Pharma develops and commercializes pharmaceutical products using proprietary drug delivery systems, with a focus on self-administered parenteral products. Their commercial products include XYOSTED (testosterone enanthate) injection, OTREXUP (methotrexate) injection, NOCDURNA (desmopressin acetate), Epinephrine Injection USP, Sumatriptan Injection USP, Makena Subcutaneous Auto Injector, and Teriparatide Injection.
- Therapeutic areas
- Men's HealthNephrologyRheumatologyEndocrinologyNeurology
- Modalities
- Self-injection technologiesDrug delivery systemsSubcutaneous injection technology
- Industry
- Biotech
02
Partnerships
Teva Pharmaceutical Industries LtdFerring PharmaceuticalsAMAG
Beyond the preview
Go deeper on Antares Pharma, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Antares Pharma, Inc..